Adagio Therapeutics, Inc. ADGI

Set alert

Price alert · ADGI

All alert types
4.64 0.00 0.00%

At close

4.40 Day range 4.74

52-week range unavailable

Open
4.62
Prev close
4.64
Mkt cap
505.68M
Vol
535.00K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
4.40
High
4.74
Forward P/E
-2.34
Beta
0.00
Short ratio
8.85
Inst. own
71.59%
Dividend
0.00
Ex-div date
Earnings
Aug 15, 2022
50-d avg
4.18
200-d avg
4.78
1y target
3.83

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ADGI has not been loaded yet. Try again in a moment.

Analyst view

Consensus: hold

Hold
Price target (mean) 3.83 -17.5% downside
Target (low)
3.00
Target (mean)
3.83
Target (high)
5.00
Ratings (-1m) 4 0 buy · 3 hold · 1 sell
  • Strong buy0
  • Buy0
  • Hold3
  • Sell1
  • Strong sell0

Recommendation trend

  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ADGI analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.49-0.52 – -0.46-0.98+50.0%00.0%3
Next quarter-0.52-0.60 – -0.39-0.77+32.5%00.0%3
Current year-2.40-2.48 – -2.25-5.32+54.9%00.0%3
Next year-1.98-2.38 – -1.31-2.40+17.5%10.23M0.0%3

Upgrades and downgrades

The latest rating changes

ADGI analyst upgrades and downgrades
DateFirmActionFromTo
Sep 16, 2022Morgan StanleyMaintained—Underweight
May 17, 2022Morgan StanleyMaintained—Underweight
Jan 6, 2022Morgan StanleyDowngradeEqual-WeightUnderweight
Dec 22, 2021JefferiesDowngradeBuyHold
Dec 15, 2021Morgan StanleyDowngradeOverweightEqual-Weight
Dec 15, 2021GuggenheimDowngradeBuyNeutral
Dec 15, 2021StifelDowngradeBuyHold
Nov 29, 2021Morgan StanleyUpgradeEqual-WeightOverweight
Aug 31, 2021Morgan StanleyInitiated—Equal-Weight
Aug 31, 2021JefferiesInitiated—Buy
Aug 31, 2021StifelInitiated—Buy
Aug 31, 2021GuggenheimInitiated—Buy